[Mutagenic and antimutagenic properties of bemitil].
Seredenin SB, Bobkov IuG, Durnev AD, Dubovskaia OIu · 1986 · Biulleten' eksperimental'noi biologii i meditsiny; 1986 Jul
Study findings
The tested genetic-toxicology assays did not detect the specified mutations or chromosomal damage, and mouse experiments found reduced damage from selected alkylating agents. This does not establish comprehensive human safety.
- Population and setting
- Experimental animals or tissue preparations
- Evidence type
- Animal / experimental
- Preparation
- See the original report; formulation details require verification.
- Source language
- rus
- Title source
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
Study limitations
- Full text and detailed methods have not been independently assessed.
- Experimental or incompletely specified settings do not establish human efficacy, dosing or safety.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed citation and English abstract checked.
Recorded source-check date: 2026-10-07. This date does not imply a completed systematic review.
Open original source or index record ↗
DOI: 10.1007/bf00840006
Citation and original source
Original source: Seredenin SB, Bobkov IuG, Durnev AD, Dubovskaia OIu. [Mutagenic and antimutagenic properties of bemitil]. Biulleten' eksperimental'noi biologii i meditsiny; 1986 Jul 1986.
Molekul research summary: https://molekul.io/research/bemitil-extra-3089347. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry